Uniphar (LON:UPR) Sets New 12-Month Low – Time to Sell?

Uniphar plc (LON:UPR) hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 166 ($2.10) and last traded at GBX 166.65 ($2.11), with a volume of 19668 shares. The stock had previously closed at GBX 171.50 ($2.17).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 310 ($3.93) price objective on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Trading Down 2.8 %

The company has a fifty day moving average of GBX 205.67 and a 200-day moving average of GBX 213.63. The company has a market capitalization of £454.99 million, a price-to-earnings ratio of 1,232.14 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43.

Uniphar Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, October 4th. Shareholders of record on Thursday, September 12th were paid a dividend of €0.01 ($0.01) per share. The ex-dividend date was Thursday, September 12th. This represents a yield of 0.25%. Uniphar’s dividend payout ratio (DPR) is presently 1,428.57%.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.